Background: In the last comprehensive review of the literature published in 2002, little information on the prevalence of orofacial clefts was available from low-and middle-income countries (LMICs).
International umbrella registries gather registry data from hospital and population-based registries in several countries. Examples include the European Surveillance of Congenital Anomalies (EUROCAT), the Latin American Collaborative Study of Congenital Malformations (ECLAMC; Castilla and Orioli, 2004) , and the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR; Botto et al., 2006) . These registries provide insight on the epidemiology across the globe, including prevalence and proportion of different kinds of clefts over time, genetic and environmental risk factors, and the effect of interventions on prevalence. However, there are large gaps in registry data from low-and middle-income countries (LMICs), limiting our ability to design and undertake effective public health and clinical interventions for the prevention of clefts and treatment for affected children.
Reports from registry data internationally suggest wide variations in the birth prevalence of cleft lip and/or cleft palate (CL/P) across settings. Reports of isolated cleft lip with or without cleft palate (CL6P) show a sevenfold range from 3.4 to 22.9 per 10,000 live births, while reports of isolated cleft palate only (CP) range from 1.3 to 25.3 per 10,000 live births, a 20-fold variation (Mossey et al., 2009 ). Detection of the latter (CP) at birth requires specialist training and is less consistent, and therefore ascertainment is almost certainly a factor in the variation in CP prevalence.
A comprehensive review of CL/P prevalence up to the year 2000 found that approximately 1 in 700 children worldwide are born with an OFC (Mossey and Little, 2002) . This figure remains the best estimate to date (Mossey and Modell, 2012) . The purpose of the current systematic review is to present and analyze published data from LMICs, to update the previous comprehensive review, address some significant gaps, and obtain a better understanding of the current burden of this disorder in low-and middle-income settings.
METHODS

Search Strategy and Selection Criteria
Because of marked variation in reporting, the outcome measure is birth prevalence of undifferentiated CL/P. Undifferentiated CL/P is defined as all CL/P, including isolated clefts, those associated with syndromes, and those associated with other anomalies (Fig.  1) . Regional comparisons are made to evaluate patterns in prevalence across settings.
We identified LMICs participating in international umbrella registries. For countries without birth registry data, we undertook a systematic review. As studies in all settings variably include live births, stillbirths, and, less frequently, terminations of pregnancy, no restrictions were made for birth outcomes. We applied no language restrictions. Studies with a median date of data collection between 1990 and 2014 were included; the 10-year overlap with the previous systematic review was done to improve the validity of the findings. Major and selected geographically-focused online databases were searched for publications, including PubMed/Medline, EMBASE, Latin American and Caribbean Health Science, IndMED, Africa-Wide Information, Open Grey, and the New York Academy of Medicine Grey Literature Report. The last search was performed on June 27, 2014.
Search terms included multiple variants of cleft lip or cleft palate or orofacial cleft or harelip, and epidemiology or prevalence or rate, and comprehensive search terms for low-and middle-income settings based on the World Bank classification of the world's economies in 2014 (World Bank, 2014) . The search terms used for PubMed are provided in Annex 4 in the supplementary material. Medical Subject Headings terms were used when available, and snowball searching was used to identify additional studies by screening the reference list of retrieved studies. Selected studies from high-income Middle Eastern countries were also included, and the titles of their respective references were screened.
Studies were included in the main analysis if they reported the birth prevalence of OFCs from a defined population, demonstrated systematic ascertainment of cases, stated the number of cases and the population denominator, and spanned at least one full calendar year. For detailed inclusion and exclusion criteria, refer to Supplementary Material Annex 2.
To address the problem of gaps in data, a secondary analysis was undertaken of lower-quality studies from countries in geographical regions with no data meeting inclusion criteria. This included smaller studies of less representative populations, such as studies from single tertiary care facilities or specialist maxillofacial surgery clinics.
Studies meeting inclusion criteria were abstracted onto a standard data extraction form, which had been piloted and refined. Studies were reviewed and data was abstracted by A.K. Recorded study characteristics included the time period, study country and subregion, study design, reference population, the birth prevalence of isolated OFCs, birth prevalence of OFCs associated with syndromes, birth prevalence of OFCs associated with other malformations, and overall population prevalence of OFCs. Where available, data were extracted for subtypes of clefts, including cleft lip with cleft palate (CLP), cleft lip (CL), and isolated cleft palate only (CP), and by breakdown of these by sex. Other variables for which data were extracted included risk factors such as consanguinity or previous family history of cleft. When possible, authors were contacted for missing data from studies in order to maximize the number of studies that met inclusion criteria. The completed data extraction form was reviewed by H.B. and P.A.M., and in the case of queries or differences, an agreement was negotiated.
The risk of bias was assessed for each individual study based on the data source, method of ascertainment, quality of ascertainment, population included in the study, and any special characteristics of the population. Studies that were deemed to be at high risk of bias, and therefore unlikely to be representative of the regional or national population, were excluded from the main analysis. The studies included in this review presented data on a wide range of variables in an inconsistent manner; however, nearly all studies provided figures for undifferentiated oral clefts (i.e., where the category and/ or cleft type was not specified). As such, the primary meta-analyses were performed on the prevalence of undifferentiated CL/P. Data from studies that did not specify if the population included isolated or undifferentiated CL/P were classified as undifferentiated. For studies presenting data exclusively on isolated CL/P, the figures provided were included in the total pooled metaanalysis of studies providing data on undifferentiated CL/P; this method will lead to an underestimation of the prevalence of isolated CL/P, if the percentage of isolated CL/P is calculated from the pooled figures obtained by meta-analysis. A separate meta-analysis was done for studies providing data on isolated CL/P as part of the sensitivity analysis.
The inclusion of less representative studies from areas with no other available data in a secondary analysis was done because these studies provide the only available data for their respective countries and thus provide a glimpse, however imperfect, into the epidemiology of CL/P in these regions. To allow for comparison between studies meeting strict inclusion criteria and second-tier inclusion criteria and thus evaluate for potential effects of bias, figures from each tier are presented separately.
Statistical Analysis
Statistical analysis was performed in Stata version 11.2 (StataCorp, College Station, TX). The pooled birth prevalence of undifferentiated OFCs was generated using the metan command, which performs metaanalysis using the inverse-variance method. Weights were calculated using random effects analysis. Because of known ethnic variations in the prevalence of clefting, pooled prevalence estimates were generated by GBD geographical super-region (Murray et al., 2012) . For China, where national-and regional-level data were available, meta-analysis was performed to compare the pooled national-level studies to the regional pooled prevalence (Supplementary Material Annex 3, Fig. 3 ). Heterogeneity was evaluated by using the Q and the I 2 statistics.
The sensitivity of the findings was evaluated by examination of the differences between the pooled prevalence of studies in the main analysis to lowerquality studies from regions with limited data and between studies presenting data on isolated cases versus those presenting undifferentiated cases. Results were compared with those reported by the EUROCAT and ECLAMC umbrella registries. EUROCAT has documented a stable birth prevalence and high ascertainment from participant registries since 1980, and as such, it serves as a reliable and valid registry for comparison (EUROCAT, 2002) . ECLAMC includes data from LMICs in Latin America; hence, it is particularly useful for comparison with other LMIC settings.
Role of the Funding Source
The study design, data collection, analysis, interpretation of data, and writing of the manuscript were undertaken independently, with no input from the study sponsors. All authors had full access to all the data in the study, and they shared responsibility for the decision to submit for publication. The systematic review was undertaken as part of a larger study of the global birth prevalence of selected congenital disorders initiated by the World Health Organization .
RESULTS
Search Results
The literature search yielded 2117 titles. After removing duplicates, the titles and abstracts of the remaining 1303 publications were screened for potential eligibility. Twelve further studies were identified through secondary searches of the references of included papers. A total of 113 papers were reviewed in full text, of which 28 studies met strict inclusion criteria for the main analysis and 4 met second-tier inclusion criteria (Supplementary Material Annex 2, Fig. 3 , flow diagram). All studies meeting second-tier criteria came from Sub-Saharan Africa (Uganda, Sudan, Kenya, and Malawi). Table 1 provides an overview of the studies.
The pooled total study population in the main analysis is 31,475,278 births from 12 countries, of which 34,653 were identified to have CL/P. The total pooled population is 1.38 per 1000 births (95% confidence interval [CI]: 1.20 to 1.56), or 1 in 730 births. In the Supplementary Material Annex 3, Table 1 provides data on findings by strict and secondary inclusion criteria and Table 2A and B provides an overview of the findings of studies that provided data on cleft subtypes. Table 1 and Figure 2A illustrate the findings across GBD super-regions. There is wide variation in CL/P prevalence between regions and significant heterogeneity within each super region. East Asia and Pacific demonstrates the highest regional prevalence, with 1.69 CL/P cases per 1000 births (95% CI: 1.48 to 1.90). All studies from this region were conducted in China, and 8 of the 12 studies provided data from a birth defects registry. Interestingly, meta-analysis of the three nationwide studies, all of which took data from the National Birth Defects Monitoring System, provides a lower CL/P prevalence, at 1.49 per 1000 live births ( 3A) when compared with the provincial studies, for which the pooled prevalence was 1.80 per 1000 births (95% CI: 1.37 to 2.23; Supplementary Material Annex 3, Fig. 3B ). The national studies presented data on infants at 28 weeks' gestation, and two studies specified that this included both live-born and stillborn infants.
South Asia and North Africa/Middle East were found to have similar reported birth prevalence of 1.28 cases per 1000 births (95% CI: 0.84 to 1.72) and 1.22 (95% CI: 0.93 to 1.50), respectively. The prevalence reported from Sub-Saharan Africa was significantly lower, at 0.73 cases per 1000 births (95% CI: 0.47 to 0.98). The data from these studies are significantly heterogeneous, and while they met strict inclusion criteria, ascertainment was variable. One of the studies calculated prevalence by comparing cases operated in seven large Smile Train centers in Nigeria to the birth rates in the relevant regions (Butali et al., 2014) . As such, it misses all undiagnosed and unoperated cases in the relevant regions and all cases in other regions and thus underestimates the actual birth prevalence. Interestingly, when the lower-quality studies from the secondary analysis are included, the total pooled prevalence increases slightly to 0.75 cases per 1000 births (95% CI: 0.56 to 0.94). This is still markedly below the figures for all other regions of the globe. The paucity of data from Sub-Saharan Africa reflects a severe lack of data from this region and an increased risk of bias in the data included in our analysis.
Latin America and the Caribbean are represented in this systematic review by only two Mexican studies. A number of Central and South American countries participate in a regional registry, ECLAMC (Castilla and Orioli, 2004) . These data were not included in this review, as the focus is to gather data from areas with significant gaps in high-quality data on the birth prevalence of OFCs. Meta-analysis of the Mexican studies showed a birth prevalence of 0.96 per 1000 births (95% CI: 0.74 to 1.18; Fig. 2A ; Supplementary Material Annex 3, Fig. 1 and 2).
Iran: A Substudy
Four of the six studies from the North Africa and Middle East super-region were from Iran. They presented data from four different parts of the country between 2005 and 2010: the northwest, southwest, and central regions and Tehran. A meta-analysis of these studies demonstrated a birth prevalence of 1.0 cases of undifferentiated CL/P per 1000 births (95%CI: 0.76 to 1.24; Supplementary Material Annex 3, Fig. 4) . A previous meta-analysis of 11 Iranian studies by Khazaei et al. (2011) also showed a birth prevalence of 1 case per 1000 births (95% CI: 0.5 to 1.5; Khazaei et al., 2011) .
Sensitivity
The pooled prevalence of studies meeting strict inclusion criteria was markedly higher than those included in the secondary analysis (1.38 compared with 0.75 CL/P cases per 1000 births). All second-tier studies were from Sub-Saharan Africa and included a total of 59 CL/P cases from a pooled population of 75,627 births (Supplementary Material Annex 3, Table 1 and Fig. 1 ). The secondary analysis included studies from single tertiary care facilities and thus were at risk for presenting a falsely high prevalence in a poorly generalizable population. However, given the high morbidity and mortality in untreated CL/P patients and the limited access to care in these settings, it is also possible that studies from referral facilities may underestimate the true population prevalence.
Interestingly, studies that specifically presented isolated CL/P demonstrated a similar prevalence to the combined pooled prevalence in studies of isolated and associated CL/P. The pooled prevalence of CL/P from the nine studies that provided data on isolated CL/P was 1.37 per 1000 births (95% CI: 0.89 to 1.85). Studies presenting undifferentiated CL/P (i.e., total CL/P with or without associated malformations or syndromes) had a pooled prevalence of 1.4 per 1000 births (95% CI: 1.21 to 1.58). Figure 2B and C display the forest plots for these respective meta-analyses. While both demonstrate marked heterogeneity, the studies presenting isolated CL/P have notably narrower confidence intervals. 2014). There is some evidence for deprivation being a risk factor for clefting; however, the precise elements of deprivation and the underlying mechanism remain poorly understood (Durning et al., 2007; Clark et al., 2003) . Careful study of the epidemiology of clefting in resourcelimited settings may help us to understand this and provide insight into how best to intervene in order to attenuate the risk of children being born with a cleft of the lip or palate (Fig. 3) .
The findings in our systematic review are indicative of a nuanced prevalence in OFCs and support the findings from large umbrella registries that the prevalence and nature of clefting are influenced by local genetic predisposition and environmental factors (EUROCAT, 2002; IPDTOC Working Group, 2010) . The heterogeneity found in our systematic review may be partly due to differences in ascertainment; however, the heterogeneity within regions and even within countries, as evidenced by the metaanalysis of Iranian studies, is also seen in long-standing umbrella registries such as EUROCAT (EUROCAT, 2002) and ECLAMC (Table 2) . Furthermore, subtypes of clefts, laterality of cleft, and the prevalence of associations are known to vary across populations (Chung and Myrianthopoulos, 1968; EUROCAT, 2002; Mossey and Modell, 2012) . The diversity in presentation of clefts makes classification and monitoring challenging, even in highincome settings with well-established birth defect registries. Furthermore, difficulties in identifying children with cleft palate are likely to lead to underascertainment even in highincome settings. Study of clefting in individual populations with multiple-source ascertainment and including terminations of pregnancy will be required to establish the true birth prevalence in different settings.
The high prevalence of CLP in East and South Asian children is in keeping with previous observations (Siva Raju, 2000; Mossey and Little, 2002; Brydon et al., 2014) . The strength and the meaning of the findings from SubSaharan Africa are less certain. There were very few studies from this large geographical region, and only three of the seven studies met strict inclusion criteria. Resource limitations across the continent hamper ascertainment and provision of care. Infants in these areas are often born at home, and their families often face significant barriers in access to care, including limited financial resources, distance to health facilities, and limited skilled pediatric health workers. Sub-Saharan Africa is thought to have a lower prevalence of clefting for genetic reasons. Previous studies have identified that people of African descent have a lower prevalence of CL/P, even after moving to a different part of the world (Chung and Myrianthopoulos, 1968; Croen et al., 1998; Kucik et al., 2012; Canfield et al., 2014) . The lower prevalence identified in the Sub-Saharan African studies may be related to a combination of poor ascertainment and lower genetic predisposition to clefting in this population.
The similarity in prevalence of isolated CL/P and combined pooled prevalence of undifferentiated CL/P is surprising, as isolated cases are only a subset of all clefts. Up to 71% of clefts are thought to be isolated, and approximately 29% are associated with other anomalies or syndromes (Mossey and Modell, 2012) . As such, it would be expected that studies measuring isolated and associated clefts together as a single group would find a higher prevalence than those measuring only isolated cases. The studies of isolated CL/P were undertaken in several different regions, including East Asia, the Middle East, and Sub-Saharan Africa, and all met strict inclusion criteria (Fig. 2B) . The comparatively high pooled prevalence in studies of isolated CL/P is likely due to more careful ascertainment in these studies rather than higher predisposition to clefting in the diverse study populations. Furthermore, this finding suggests that the overall pooled prevalence in this systematic review underestimates the true prevalence of undifferentiated CL/P worldwide.
While the overall figure for CL/P prevalence is similar to that of the previous systematic review, a careful comparison is not possible because of significant differences in the data presented and the method of analysis. The previous review was more comprehensive in that it included data from high-, middle-, and low-income settings, and it included registry data as well as epidemiological studies.
Validity
As we sought to include studies from places where registry data are not available, we did not include registry data from LMIC countries participating in the ECLAMC registry.
In 2002, EUROCAT reported a regional prevalence of undifferentiated CL/P at 1.52 per 1000 births (95% CI: 1.49 to 1.55). The prevalence of isolated CL/P was 1.0 per 1000 births (95% CI: 0.5 to 1.5). These figures include live births, stillbirths, and terminations of pregnancy. Significant variation was seen across geographical regions within and between countries, with the lowest reported rate in El Valles, Spain, at 0.63 cases per 1000 births and the highest in Finland at 2.62 per 1000 births (EUROCAT, 2002) . It must be noted that there are ethnic and environmental exposure differences between EUROCAT member registry populations and those from the studies included in the systematic review.
ECLAMC data are somewhat more varied, with prevalence figures ranging from 2.68 per 1000 births in Bolivia to 1.18 in Uruguay (Table 2) . ECLAMC collects data from hospital registries, which participate voluntarily in the umbrella registry. Chile, Argentina, Brazil, and Colombia each have several hospital registries participating in ECLAMC and are thus most likely to be representative of their respective national populations and therefore the most reliable data for comparison. Combined data from ECLAMC registries for gives a prevalence of 1.87 cases per 1000 births (combined stillborn and live born). This prevalence is markedly higher than the findings from the two Mexican studies included in our systematic review. The ECLAMC figures for Argentina are higher than those registered in the Argentina National Registry of Congenital Anomalies (RENAC). Table 3 in the supplementary material provides RENAC prevalence figures for total OFCs and subtypes for the years 2010 to 2013. While ECLAMC includes data from a few Argentinian hospital-based registries, RENAC is a national registry with a broader catchment, including all hospitals with 1000 or more births per year as well as specialist hospitals (Groisman et al., 2013) . There are likely to be variations in quality of ascertainment and differences in prevalence based on the level of specialization of hospitals participating in the two registries.
Heterogeneity
Significant heterogeneity was observed in the total pooled estimate (I 2 ¼ 99.5%; Q-statistic, P , .001). Marked heterogeneity was also observed in most of the regional pooled estimates and in the pooled estimate of studies meeting first-tier inclusion criteria (Supplementary Material Annex 3, Figs. 1 and 2 ). There was also substantial heterogeneity amongst studies from SubSaharan Africa (I 2 ¼ 85.2%; Q-statistic, P , .001). There are insufficient studies from most regions to assess for heterogeneity because of changes in prevalence over time.
There are many potential sources of heterogeneity, the most likely of which are inconsistent and limited ascertainment of cases within and between countries and regions and variable methods of data collection and reporting, which lead to registration bias. Only two studies used more than one source of ascertainment. As such, there is large room for error, particularly in failure to detect isolated cleft palate only, which is a challenge even in high-income settings with specialized health care workers. Supplementary Material Annex 3 Tables 2A  and B give an overview of the studies that provided data on cleft subtypes. Cleft palate was notably absent or surprisingly low in a number of these studies. Accurate ascertainment in low-and middle-income settings is hampered by a limited number of skilled workers in obstetrics and pediatrics, with subsequent limited access to maternal and newborn care and eventual diagnosis and treatment.
Another source of heterogeneity is the variability in the size of the studies, ranging from 6621 births to 12,058,550 births. Furthermore, clefts were defined variably, particularly with regard to the reporting of isolated versus associated CL/P. Finally, the definitions of the reference population were variable; some studies included live births only, while others variably included stillbirths, terminations, and fetal deaths. Taken together, these differences in the definition of cases and the reference population are likely to contribute to the heterogeneity seen in the overall findings presented here.
Limitations
There are a number of limitations in our systematic review, which reflect large gaps in prevalence data that persist in low-and middle-income settings. The factors described above that contribute to the heterogeneity between the above studies also limit the strength of the findings. Furthermore, studies used varied and often unclear definitions of cases and of the study population. While studies with very poor ascertainment were excluded, the included studies had variable quality of ascertainment, even in those that met strict inclusion criteria. The assumption was made that the data presented were for all children born with clefts, including those with syndromes and other malformations. Accordingly, the figures presented here are those for undifferentiated CL/P, and a meta-analysis of studies that specifically provided data on isolated CL/ P was performed to evaluate the sensitivity of the overall findings. As only a few studies provided information on cleft subtypes and sex distribution, these were not statistically analyzed.
It is not clear how to interpret the data included in the secondary analysis. The studies were undertaken in referral facilities and therefore risk overestimating the true birth prevalence of CL/P. Simultaneously, the settings are characterized by significant barriers to care, which are likely to lead to missed children who never receive care, are never referred, or die before they reach a referral center, thus leading to underestimation of the true prevalence. At this time, they provide a best estimate where no other data are available.
Implications for Future Research
The findings and the limitations of this systematic review demonstrate that the greatest need is for research that is comparable across settings (Fig. 3) . While establishing registries is the gold standard, it is a timeand resource-intensive task that is less likely to be prioritized or sustainable in LMICs.
For countries with severe resource limitations, a good alternative would be to undertake population-based studies, as the studies included in this review have done. However, to be a useful resource for intercenter comparisons, such studies must be comparable. A recent initiative to standardize the classification of cleft subtypes has been undertaken at the World Health Organization Collaborating Centre for Craniofacial Anomalies at the University of Dundee, United Kingdom, by replacing the ICD-10 classification for OFC (which is considered by clinicians to be unfit for purpose) and recommending an alternative based on that described by Kriens in 1989 as the LAHSHAL system. It may be possible for this to be adopted internationally (McBride et al., 2015) .
Annex 1 in the supplementary material provides a suggested structure for future data collection and reporting. To ensure comparable data, studies should adopt clear and broadly used definitions when reporting outcomes, and they should explicitly state this in the text of eventual publications.
Ultimately, the objective in reporting on CL/P must be, from both the scientific and humanitarian viewpoints, to advance our knowledge and understanding of causative factors of OFCs, to enable the design and implementation of primary preventative measures. Developing a clear understanding of the true scale of the problem and the nuances in different populations is the first step toward this goal.
CONCLUSION
Using the best evidence available to date, it appears that in low-and middle-income settings, 1 in every 730 children is born with a cleft lip and/or palate. Although prevalence studies in these settings have increased in number and improved during the past 15 years, the data presented remain limited and difficult to compare, and the findings from this systematic review should be interpreted with caution. Future research should use a standard classification system, with standard criteria for data collection and presentation, to optimize comparability across settings. Research should also include health economics data order to estimate the cost of treatment as compared with that of potential preventive measures. As there is an association between deprivation and CL/P, understanding the true scale of clefting and associated risk factors for children born in low-and middle-income settings is a matter of both scientific importance and one of social justice.
